By Joe Mellor, Deputy Editor Looks like Noel isn’t having anything to do with the Ice Bucket challenge his brother set him, maybe it is clogging up his Facebook news feed and it is starting to wear a bit thin, who knows? Well as ever it is a great excuse ...
By Joe Mellor, Deputy Editor Liam Gallagher took up the ice bucket challenge and decided to call out his estranged brother Noel to throw some cold water over himself, but this is likely to fuel the fire between the warring siblings. But what better opportunity to revisit some of Liam’s ...
David Landon Cole The bitcoin - a currency based on a hash function - is often touted as the future and a recent article on The London Economic buys into that. I have a few objections with the piece that I'd like to look at. The premise for the article ...
By Joe Mellor, Deputy Editor Viva Fidel! Cuba celebrated Castro's 88th birthday yesterday and he famously survived 638 assassination attempts – the Americans tried so many ways that they had to get creative. Here are his top 10 assassination attempts 1. Poisoned milkshake. The attempt went wrong when the pill ...
By Abbey Haigh, 21 My problems all started just after I’d hit puberty, I was about 13 when I got my first urinary tract infection. In the beginning drinking lots of water and bearing the pain for a few days meant it would clear up for a while ...
By David de Winter - Sports Writer Saturday sees the start of the 101st edition of the world’s most famous bicycle race, the eponymous Tour de France. And where does this three week lycra-clad epic begin? Paris? Non. Some chic, picturesque village in the south of France? Absolutement non. ...
By Simon Richardson Around a year ago, I was in the middle of a gruelling battle against drug-resistant tuberculosis (TB), taking a cocktail of drugs with horrific side effects and fighting for my life. If you’d told me then that just over a year later I’d be a fully trained ...
By Guy Dorrell @GuyDorrellEsq Pfizer’s abortive bid to take control of Astra Zenica in May 2014 was widely commented to have been motivated, at least in part, by Research and Development issues. More specifically, Pfizer has for some time relied upon the cash-cows of its existing products; bolstering its share ...
By Toby James Last month, American pharmaceuticals giant Pfizer had their ‘final offer’ for their proposed takeover of the British company AstraZeneca rejected. This offered shareholders £24.76 and 1.747 shares for each share they owned, valuing each share at £55 and the company as a whole at £69 billion, yet was ...